Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Clinical trial NCT04052425 · COMPLETED

Trial details

NCT number: NCT04052425
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-segmental Vitiligo

Start date: 2019-09-20
Primary completion: 2021-03-18
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.